Nearly a fifth of 11,000 people enrolled so far in a 30,000-volunteer U.S. trial testing a COVID-19 vaccine from Pfizer and German partner BioNTech are Black or Latino, groups among the hardest hit...
from NDTV News - Topstories https://ift.tt/32w5usP
via IFTTT
from NDTV News - Topstories https://ift.tt/32w5usP
via IFTTT
Comments
Post a Comment